These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
700 related items for PubMed ID: 31248375
1. Rapid, low cost and sensitive detection of Calreticulin mutations by a PCR based amplicon length differentiation assay for diagnosis of myeloproliferative neoplasms. Trung NT, Quyen DT, Hoan NX, Giang DP, Trang TTH, Velavan TP, Bang MH, Song LH. BMC Med Genet; 2019 Jun 27; 20(1):115. PubMed ID: 31248375 [Abstract] [Full Text] [Related]
2. Molecular genetics of BCR-ABL1 negative myeloproliferative neoplasms in India. Rabade N, Subramanian PG, Kodgule R, Raval G, Joshi S, Chaudhary S, Mascarenhas R, Tembhare P, Gujral S, Patkar N. Indian J Pathol Microbiol; 2018 Jun 27; 61(2):209-213. PubMed ID: 29676359 [Abstract] [Full Text] [Related]
3. CALR, JAK2, and MPL mutation profiles in patients with four different subtypes of myeloproliferative neoplasms: primary myelofibrosis, essential thrombocythemia, polycythemia vera, and myeloproliferative neoplasm, unclassifiable. Kim SY, Im K, Park SN, Kwon J, Kim JA, Lee DS. Am J Clin Pathol; 2015 May 27; 143(5):635-44. PubMed ID: 25873496 [Abstract] [Full Text] [Related]
4. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond. Michiels JJ, Berneman Z, Schroyens W, De Raeve H. Acta Haematol; 2015 May 27; 133(1):36-51. PubMed ID: 25116092 [Abstract] [Full Text] [Related]
9. [The genetic characteristics of BCR-ABL-negative myeloproliferative neoplasms]. Lyu XD, Li YW, Guo Z, Xin YP, Hu JY, Fan RH, Song YP. Zhonghua Nei Ke Za Zhi; 2020 Jan 01; 59(1):35-39. PubMed ID: 31887834 [Abstract] [Full Text] [Related]
12. MOLECULAR GENETIC ABNORMALITIES IN THE GENOME OF PATIENTS WITH Ph-NEGATIVE MYELOPROLIFERATIVE NEOPLASIA AFFECTED BY IONIZING RADIATION AS A RESULT OF THE CHORNOBYL NUCLEAR ACCIDENT. Poluben LO, Neumerzhytska LV, Klymenko SV, Fraenkel P, Balk C, Shumeiko OO. Probl Radiac Med Radiobiol; 2020 Dec 01; 25():362-373. PubMed ID: 33361847 [Abstract] [Full Text] [Related]
13. The Prevalence of JAK2, MPL, and CALR Mutations in Chinese Patients With BCR-ABL1-Negative Myeloproliferative Neoplasms. Lin Y, Liu E, Sun Q, Ma J, Li Q, Cao Z, Wang J, Jia Y, Zhang H, Song Z, Ai X, Shi L, Feng X, Li C, Wang J, Ru K. Am J Clin Pathol; 2015 Jul 01; 144(1):165-71. PubMed ID: 26071474 [Abstract] [Full Text] [Related]
14. The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Wu Z, Zhang X, Xu X, Chen Y, Hu T, Kang Z, Li S, Wang H, Liu W, Ma X, Guan M. J Hematol Oncol; 2014 Jul 15; 7():48. PubMed ID: 25023898 [Abstract] [Full Text] [Related]